Lilac Medicines Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 Mumbai, Maharashtra, India Amalgamated
Last Updated:
Access Report
About Lilac Medicines Private Limited

Lilac Medicines Private Limited, a amalgamated private limited company, was established on 02 January 2008 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232MH2008PTC177226. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vijay Bhiva Pashte (Director), Mohd Latif Khan Ummed Ali (Director). Past directors included Raj Kumar Saraf, Santos Kumar Sahoo, Vinod Bana. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at 411, Vyapar Bhavan, 49, P.D'Mello Road,, Mumbai, Maharashtra, 400009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MH2008PTC177226

  • Registration Number

    177226

  • Incorporation Date

    02 January 2008

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 4 Months
  • Last Filing with ROC 31 Mar 2014
Company report

Lilac Medicines Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Lilac Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lilac Medicines Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Bhiva Pashte Director 09 Dec 2014 Current
Mohd Latif Khan Ummed Ali Director 31 Jul 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jan 2010 Past
Pramod Abcsdd Director 16 Dec 2014 Past
Pramod Abcsdd Director 17 Feb 2009 Past
Pramod Abcsdd Director 01 Jan 2010 Past
Pramod Abcsdd Director 01 Jan 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lilac Medicines.

Enhance accessibility to Lilac Medicines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Lilac Medicines revenue growth over time
Lilac Medicines profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lilac Medicines?

Unlock access to Lilac Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lilac Medicines?

Unlock and access historical data on people associated with Lilac Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lilac Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lilac Medicines's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lilac Medicines
Recent Activity within the Organization
  • Director Appointment

    The activity Vijay Bhiva Pashte was appointed as a Director was appointed as a Director on 09 Dec 2014 & has been associated with this company since 11 years 5 months . was completed.

  • Annual General Meeting

    Lilac Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Lilac Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Mohd Latif Khan Ummed Ali was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 16 years 9 months . was documented.

  • Company Incorporation

    Lilac Medicines Private Limited was registered on 02 Jan 2008 with Roc Mumbai & aged 18 years 4 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lilac Medicines Private Limited?

The CIN of Lilac Medicines Private Limited is U24232MH2008PTC177226.

Where is Lilac Medicines Private Limited headquartered?

Lilac Medicines Private Limited is headquartered at 411, Vyapar Bhavan, 49, P.D'Mello Road,, Mumbai, Maharashtra, 400009.

When was Lilac Medicines Private Limited incorporated?

Lilac Medicines Private Limited was incorporated on 02 January 2008.

Who are the current directors of Lilac Medicines Private Limited?

The current directors of Lilac Medicines Private Limited are

What is the primary industry of Lilac Medicines Private Limited?

The primary industry of Lilac Medicines Private Limited is Chemicals.

Is Lilac Medicines Private Limited a listed company?

Lilac Medicines Private Limited is unlisted.

What is the capital structure of Lilac Medicines Private Limited?

The authorized capital of Lilac Medicines Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available